CS
BLUE

Credit Suisse’s bluebird bio BLUE Stock Holding History

Credit Suisse’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,636
Closed -$2.33M – 4395
2021
Q2 		$2.33M Buy
5,636
+2,216
+65% +$878K ﹤0.01% 2742
2021
Q1 		$1.34M Sell
3,420
-15,540
-82% -$7.65M ﹤0.01% 3108
2020
Q4 		$10.6M Buy
18,960
+3,242
+21% +$2.05M 0.01% 1534
2020
Q3 		$11M Buy
15,718
+14,784
+1,583% +$11.5M 0.01% 1328
2020
Q2 		$739K Buy
+934
New +$704K ﹤0.01% 3097
2019
Q4 		– Sell
-26,881
Closed -$32M – 4160
2019
Q3 		$32M Buy
+26,881
New +$41.1M 0.03% 667

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Credit Suisse's BLUE Position: Q1 2024 in Review

Credit Suisse sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 3,532 shares — an estimated $97.5K sold.

Credit Suisse first reported a position in BLUE in Q1 2014 and held it in 40 quarters. The position peaked at $84.3M in Q2 2021. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.

  • Credit Suisse reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
  • Credit Suisse sold 3,532 bluebird bio shares in Q1 2024, an estimated $97.5K.
  • Credit Suisse first reported a position in bluebird bio in Q1 2014 and held it in 40 quarters.
  • Credit Suisse's bluebird bio position peaked at $84.3M in Q2 2021.
  • 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.